Your browser doesn't support javascript.
loading
AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma.
Noy, Ariela; Lee, Jeannette Y; Cesarman, Ethel; Ambinder, Richard; Baiocchi, Robert; Reid, Erin; Ratner, Lee; Wagner-Johnston, Nina; Kaplan, Lawrence.
  • Noy A; Department of Medicine, Memorial Sloan Kettering Cancer Center, and Weill Cornell Medical Center, New York, NY;
  • Lee JY; University of Arkansas Medical Center, Little Rock, AR;
  • Cesarman E; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY;
  • Ambinder R; Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD;
  • Baiocchi R; Division of Hematology, Ohio State Medical Center, Columbus, OH;
  • Reid E; University of California San Diego, Moores Cancer Center, La Jolla, CA;
  • Ratner L; Division of Oncology, Washington University School of Medicine, St. Louis, MO; and.
  • Wagner-Johnston N; Division of Oncology, Washington University School of Medicine, St. Louis, MO; and.
  • Kaplan L; Department of Medicine, University of California San Francisco, San Francisco, CA.
Blood ; 126(2): 160-6, 2015 Jul 09.
Article en En | MEDLINE | ID: mdl-25957391

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Infecciones por VIH / Linfoma de Burkitt / Anticuerpos Monoclonales de Origen Murino Tipo de estudio: Clinical_trials / Guideline / Risk_factors_studies / Systematic_reviews Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2015 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Infecciones por VIH / Linfoma de Burkitt / Anticuerpos Monoclonales de Origen Murino Tipo de estudio: Clinical_trials / Guideline / Risk_factors_studies / Systematic_reviews Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2015 Tipo del documento: Article